What Researchers Did
Researchers evaluated the effects of intratympanic dexamethasone injection compared to other dexamethasone administration methods in 78 patients with profound sudden hearing loss.
What They Found
The percentage of patients achieving a hearing threshold improvement of more than 30 dB was 81.82% in Group I, 83.3% in Group II, and 88.64% in Group III, with no significant difference between groups (P=0.726). After 30 days, the pure tone threshold improvement was 41.36 dB for local and general administration, 43.08 dB for intravenous injection, and 51.70 dB for intratympanic injection.
What This Means for Canadian Patients
This study suggests that intratympanic dexamethasone injection may offer comparable or slightly better hearing improvement for profound sudden hearing loss compared to intravenous or combined local and general administration. Canadian patients with profound sudden hearing loss might consider this as a viable treatment option, potentially leading to similar or improved hearing outcomes.
Canadian Relevance
This study was conducted in China and has no direct Canadian connection.
Study Limitations
A key limitation is the non-randomized patient assignment to treatment groups, which could introduce selection bias.